Search

Noblis Receives U.S. Patent for SNP Analysis and Genome Sequencing System and Methods

Noblis Receives U.S. Patent for SNP Analysis and Genome Sequencing System and Methods

Innovative algorithm powers BioVelocity®, Noblis’ DNA alignment tool.

PR Newswire

RESTON, Va., April 24, 2019 /PRNewswire-PRWeb/ — Noblis, Inc., a leading provider of science, technology, and strategy solutions, announces today the award of U.S. patent 10,191,929, “Systems and Methods for SNP Analysis and Genome Sequencing.” Noblis’ new system and methods make it easier, quicker, and more efficient to conduct a variety of advanced bioinformatic analyses, including SNP calling, metagenomic analysis, and conserved and signature sequence detection.

Noblis’ patented technology is the basis of BioVelocity®, a DNA alignment bioinformatics tool. Using a fast and accurate hashing algorithm, BioVelocity indexes billions of nucleotides across tens of thousands of references, or more and aligns reads to a set of references. This index is then used to align “one to many” read files.

This advancement is particularly impactful as genomic sequencing becomes increasingly less expensive and outputs continue to increase. Thus, there is a heightened need for data analysis to quickly and efficiently process genomic data.

“Noblis is proud that our proactive investment in genomic research, high performance computing, and data analytics has led to our patented BioVelocity technology, an industry leading tool that has made a tangible impact on the public heath and national security priorities of our federal clients,” Chris Barnett, Noblis Chief Technology Officer, said.

“Bioinformatics research will continue to play a major role in ensuring food safety, preventing disease, and reducing the threat of biological warfare,” Dr. Sterling Thomas, Noblis’ Defense and Homeland Security Chief Scientist, said. “As such, Noblis bioinformatics is dedicated to a steadfast investment in advancing this emerging area of research and development.”

To learn more about Noblis’ BioVelocity tool, as well as the company’s other bioinformatics tools and life science research, visit bioportal.noblis.org.

Noblis is a dynamic science, technology, and strategy organization dedicated to creating forward-thinking technical and advisory solutions in the public interest. We bring the best of scientific thought, management, and engineering expertise together in an environment of independence and objectivity to deliver enduring impact on federal missions.

Noblis works with a wide range of government clients in the defense, intelligence and federal civil sectors. Together with our wholly owned subsidiary, Noblis ESI, we tackle the nation’s toughest problems and support our clients’ most critical missions. Learn more at noblis.org and noblis-esi.com.

 

SOURCE Noblis



Congress Updates

House Heads For Recess Without Moving On NDAA After Procedural Vote Fails

The House will leave for the Fourth of July recess without moving forward on its $1.15 trillion fiscal year 2027 National Defense Authorization Act (NDAA), with a procedural vote to […]


Bipartisan Group Of House Members Introduce U.S.-Ukrainian Co-Production Bill For Unmanned Systems

A bipartisan group of six House legislators have introduced the Strategic Unmanned Systems Partnership Act–a bill to improve drone collaboration between the U.S. and Ukraine. Rep. Michael McCaul (R-Texas), the […]


Will $4 Billion For SB-AMTI/Space Data Network Backbone In Supplemental Reduce Or Add To Planned Funding For Systems In Reconciliation?

Nearly all of the Department of the Air Force’s fiscal 2027 procurement and research and development (R&D) budget for space-based air moving target indication (SB-AMTI) and the Space Data Network […]


House Appropriators ‘Concerned’ With JLTV A2 Delays, Shift Funds For Marines’ Second Supplier Effort

House appropriators have said they’re “seriously concerned” with Joint Light Tactical Vehicle (JLTV) A2 delays, as their fiscal year 2027 defense spending bill shifts funds to support the Marine Corps’ […]